{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:26:26Z","timestamp":1747221986562,"version":"3.40.5"},"reference-count":36,"publisher":"Sociedade Brasileira de Cardiologia","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,18]]},"DOI":"10.36660\/abc.20190683","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T15:01:27Z","timestamp":1602774087000},"page":"538-544","source":"Crossref","is-referenced-by-count":5,"title":["Impacto dos \u00cdndices Aterog\u00eanicos em Estenose do Enxerto de Veia Safena"],"prefix":"10.36660","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-4212","authenticated-orcid":false,"given":"Fethi","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-3747","authenticated-orcid":false,"given":"Salih","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-5799","authenticated-orcid":false,"given":"Mehmet","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-7488","authenticated-orcid":false,"given":"Arafat","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-3642","authenticated-orcid":false,"given":"Mehmet","family":"Kucukosmanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3895-1923","authenticated-orcid":false,"given":"Mustafa","family":"Dogdus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"8","key":"key20201015110110_B1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jcin.2011.05.014","article-title":"Saphenous vein graft intervention","volume":"4","author":"Lee","year":"2011","unstructured":"1. Lee MS, Park SJ, Kandzari DE, Kirtane AJ, Fearon WF, Brilakis ES, et al. Saphenous vein graft intervention. JACC Cardiovasc Interv. 2011;4(8):831-43.","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"key20201015110110_B2","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","article-title":"Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a department of veterans affairs cooperative study","volume":"44","author":"Goldman","year":"2004","unstructured":"2. Goldman S, Zadina K, Moritz T, Ovitt T, Seth G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a department of veterans affairs cooperative study. J Am Coll Cardiol. 2004;44(11):2149-56.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20201015110110_B3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0003-4975(96)01045-4","article-title":"Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response","volume":"63","author":"Allaire","year":"1997","unstructured":"3. Allaire E, Clowes AW. Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg. 1997;63(2):582-91.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"key20201015110110_B4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.coph.2012.02.012","article-title":"Perivascular administration of drugs and genes as a means of reducing vein graft failure","volume":"12","author":"Wiedemann","year":"2012","unstructured":"4. Wiedemann D, Kocher A, Bonaros N, Semsroth S, Laufer G, Grimm M, et al. Perivascular administration of drugs and genes as a means of reducing vein graft failure. Curr Opin Pharmacol. 2012;12(2):203-16.","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"key20201015110110_B5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","unstructured":"5. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97(9):916-31.","journal-title":"Circulation"},{"issue":"3","key":"key20201015110110_B6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0003-4975(97)00057-X","article-title":"Endothelial cell injury in cardiovascular surgery: atherosclerosis","volume":"63","author":"Boyle","year":"1997","unstructured":"6. Boyle EM Jr, Lille ST, Allaire E, Clowes AW, Verrier ED. Endothelial cell injury in cardiovascular surgery: atherosclerosis. Ann Thorac Surg. 1997;63(3):885-94.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"key20201015110110_B7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-8703(86)90481-3","article-title":"Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple risk factor intervention trial","volume":"112","author":"Kannel","year":"1986","unstructured":"7. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple risk factor intervention trial. Am Heart J. 1986;112(4):825-36.","journal-title":"Am Heart J"},{"issue":"20","key":"key20201015110110_B8","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study","volume":"256","author":"Castelli","year":"1986","unstructured":"8. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA. 1986;256(20):2835-8.","journal-title":"JAMA"},{"issue":"7897","key":"key20201015110110_B9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease","volume":"1","author":"Miller","year":"1975","unstructured":"9. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet. 1975;1(7897):16-9.","journal-title":"Lancet"},{"issue":"2","key":"key20201015110110_B10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-8703(86)90296-6","article-title":"The triglyceride issue: a view from Framingham","volume":"112","author":"Castelli","year":"1986","unstructured":"10. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 1986;112(2):432-7.","journal-title":"Am Heart J"},{"issue":"3","key":"key20201015110110_B11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jama.294.3.326","article-title":"Non-HDL cholesterol, apolipoprotein A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women","volume":"294","author":"Ridker","year":"2005","unstructured":"11. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoprotein A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294(3):326-33.","journal-title":"JAMA"},{"issue":"9","key":"key20201015110110_B12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","article-title":"Cholesterol and coronary heart disease: predicting risks by levels and ratios","volume":"121","author":"Kinosian","year":"1994","unstructured":"12. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994;121(9): 641-7.","journal-title":"Ann Intern Med"},{"issue":"11","key":"key20201015110110_B13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","article-title":"Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality","volume":"161","author":"Cui","year":"2001","unstructured":"13. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161(11):1413-9.","journal-title":"Arch Intern Med"},{"issue":"5","key":"key20201015110110_B14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1179\/1743132813Y.0000000206","article-title":"Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study","volume":"35","author":"Wu","year":"2013","unstructured":"14. Wu J, Chen S, Liu L, Gao X, Zhou Y, Wang C, et al. Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study. Neurol Res. 2013;35(5):505-11.","journal-title":"Neurol Res"},{"issue":"7","key":"key20201015110110_B15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1373\/clinchem.2004.033175","article-title":"Atherogenic index of plasma [log(triglycerides\/HDL-cholesterol)]: theoretical and practical implications","volume":"50","author":"Dobiasova","year":"2004","unstructured":"15. Dobiasova M. Atherogenic index of plasma [log(triglycerides\/HDL-cholesterol)]: theoretical and practical implications. Clin Chem. 2004;50(7):1113-5.","journal-title":"Clin Chem"},{"issue":"7","key":"key20201015110110_B16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","article-title":"The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL)","volume":"34","author":"Dobiasova","year":"2001","unstructured":"16. Dobiasova M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583-8.","journal-title":"Clin Biochem"},{"issue":"2","key":"key20201015110110_B17","first-page":"148","article-title":"Biochemical markers of atherosclerosis","volume":"27","author":"Deric","year":"2008","unstructured":"17. Deric M, Kojic-Damjanov S, Cabarkapa V, Eremic N. Biochemical markers of atherosclerosis. JMB. 2008;27(2):148-53.","journal-title":"JMB"},{"issue":"4","key":"key20201015110110_B18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/ejcts\/ezv268","article-title":"Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16,900 patients investigated in randomized controlled trials","volume":"49","author":"Deppe","year":"2016","unstructured":"18. Deppe AC, Arbash W, Kuhn EW, Slottosch I, Scherner M, Liakopoulos OL, et al. Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16,900 patients investigated in randomized controlled trials. Eur J Cardiothorac Surg. 2016;49(4):1031-41.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"key20201015110110_B19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.athoracsur.2016.09.024","article-title":"No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results","volume":"103","author":"Kim","year":"2017","unstructured":"19. Kim YH, Oh HC, Choi JW, Hwang HY, Kim KB. No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results. Ann Thorac Surg. 2017;103(5):1489-97.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"key20201015110110_B20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4161\/oxim.3.3.11757","article-title":"Role of gender, smoking profile, hypertension, and diabetes on saphenous vein and internal mammary artery endothelial relaxation in patients with coronary artery bypass grafting","volume":"3","author":"Muir","year":"2010","unstructured":"20. Muir AD, McKeown PP, Bayraktutan U. Role of gender, smoking profile, hypertension, and diabetes on saphenous vein and internal mammary artery endothelial relaxation in patients with coronary artery bypass grafting. Oxid Med Cell Longev. 2010;3(3):199-205.","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"key20201015110110_B21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/bjs.1800801007","article-title":"Smoking impairs endothelium-dependent relaxation of saphenous vein","volume":"80","author":"Higman","year":"1993","unstructured":"21. Higman DJ, Greenhalgh RM, Powell JT. Smoking impairs endothelium-dependent relaxation of saphenous vein. Br J Surg. 1993;80(10):1242-5.","journal-title":"Br J Surg"},{"issue":"4","key":"key20201015110110_B22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MCA.0000000000000240","article-title":"The relationship between vitamin D levels and saphenous vein graft patency","volume":"26","author":"Sen","year":"2015","unstructured":"22. Sen F, Yilmaz S, Balci KG, Sen O, G\u00fcl M, \u00c7ay S, et al. The relationship between vitamin D levels and saphenous vein graft patency. Coron Artery Dis. 2015;26(4):328-32.","journal-title":"Coron Artery Dis"},{"issue":"29","key":"key20201015110110_B23","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of 10 Societies and by Invited experts)Developed With the Special Contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","unstructured":"23. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of 10 Societies and by Invited experts)Developed With the Special Contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81.","journal-title":"Eur Heart J"},{"issue":"4","key":"key20201015110110_B24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3797\/scipharm.1407-16","article-title":"Pioglitazone and endothelial dysfunction pleiotropic effects and possible therapeutic implications","volume":"82","author":"Radenkovic","year":"2014","unstructured":"24. Radenkovic M. Pioglitazone and endothelial dysfunction pleiotropic effects and possible therapeutic implications. Sci Pharm. 2014;82(4):709-21.","journal-title":"Sci Pharm"},{"issue":"1","key":"key20201015110110_B25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2014.10.013","article-title":"Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the project of Ex-vivo Vein graft engineering via transfection IV trial","volume":"169","author":"Koshizaka","year":"2015","unstructured":"25. Koshizaka M, Lopes RD, Reyes EM, Gibson CM, Schulte P, Hafley GE, et al. Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the project of Ex-vivo Vein graft engineering via transfection IV trial. Am Heart J. 2015;169(1):175-84.","journal-title":"Am Heart J"},{"key":"key20201015110110_B26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"253","author":"Catapana","year":"2016","unstructured":"26. Catapana AL, Graham I, Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Oct;253:281-344.","journal-title":"Atherosclerosis"},{"key":"key20201015110110_B27","doi-asserted-by":"crossref","DOI":"10.1186\/1749-8090-8-172","article-title":"Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial","volume":"8","author":"Jerzewski","year":"2013","unstructured":"27. Jerzewski K, Ruel M, Voisine P, May MR, Kulik A. Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial. J Cardiothorac Surg. 2013 Jul 10;8:172.","journal-title":"J Cardiothorac Surg"},{"issue":"5","key":"key20201015110110_B28","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.athoracsur.2009.06.009","article-title":"Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease","volume":"88","author":"Hata","year":"2009","unstructured":"28. Hata M, Takayama T, Sezai A, Yoshitake I, Hirayama A, Minami K. Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease. Ann Thorac Surg. 2009;88(5):1440-4.","journal-title":"Ann Thorac Surg"},{"issue":"20","key":"key20201015110110_B29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","unstructured":"29. Ridker PM, Rifai N, Rose RL, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557-65.","journal-title":"N Engl J Med"},{"key":"key20201015110110_B30","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-017-0418-5","article-title":"Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction","volume":"16","author":"Gao","year":"2017","unstructured":"30. Gao M, Zheng Y, Zhang W, Cheng Y, Wang L, Qin L. Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction. Lipids Health Dis. 2017 Jan 23;16:20.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"key20201015110110_B31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.5603\/KP.a2015.0086","article-title":"Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people","volume":"73","author":"Zhu","year":"2015","unstructured":"31. Zhu L, Lu Z, Zhu L, Ouyang X, Yang Y, He W, et al. Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people. Kardiol Pol. 2015;73(10):931-8.","journal-title":"Kardiol Pol"},{"issue":"11","key":"key20201015110110_B32","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1373\/clinchem.2003.022558","article-title":"Fractional esterification rate of cholesterol and triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography","volume":"49","author":"Frohlich","year":"2003","unstructured":"32. Frohlich J, Dobiasova M. Fractional esterification rate of cholesterol and triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49(11):1873-80.","journal-title":"Clin Chem"},{"key":"key20201015110110_B33","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-016-0222-7","article-title":"Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women","volume":"15","author":"Nansseu","year":"2016","unstructured":"33. Nansseu JRN, Moor VJA, Nouaga MED, Zing-Awona-B, Tchanana G, Ketcha A. Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women. Lipids Health Dis. 2016 Mar 9;15:49.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"key20201015110110_B34","first-page":"106","article-title":"Low plasma atherogenic index associated with poor prognosis in hospitalized patients with acute myocardial infarction","volume":"48","author":"Hartopo","year":"2016","unstructured":"34. Hartopo AB, Arso IA, Setianto BY. Low plasma atherogenic index associated with poor prognosis in hospitalized patients with acute myocardial infarction. Acta Med Indones. 2016;48(2):106-13.","journal-title":"Acta Med Indones"},{"key":"key20201015110110_B35","first-page":"10","article-title":"Analysis on levels of non-high density lipoproterin cholesterol and atherogenic index of plasma in normal population","volume":"1","author":"Wang","year":"2008","unstructured":"35. Wang YM, Chen XF, Yuan Q. Analysis on levels of non-high density lipoproterin cholesterol and atherogenic index of plasma in normal population. Zhejiang Prev Med. 2008;1:10-4.","journal-title":"Zhejiang Prev Med"},{"key":"key20201015110110_B36","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-10-20","article-title":"Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: discriminant ratio and unbiased equivalence","volume":"10","author":"Hermans","year":"2011","unstructured":"36. Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: discriminant ratio and unbiased equivalence. Cardiovasc Diabetol. 2011 Feb 28;10:20.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/abccardiol.org\/article\/impacto-dos-indices-aterogenicos-em-estenose-do-enxerto-de-veia-safena\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T16:56:46Z","timestamp":1612803406000},"score":1,"resource":{"primary":{"URL":"http:\/\/abccardiol.org\/article\/impacto-dos-indices-aterogenicos-em-estenose-do-enxerto-de-veia-safena\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,18]]}},"alternative-id":["10.36660\/abc.20190683"],"URL":"https:\/\/doi.org\/10.36660\/abc.20190683","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}